Edison issues update on ASLAN Pharmaceuticals (ASLN)
July 09, 2018 11:23 ET
|
Edison Group
LONDON, July 09, 2018 (GLOBE NEWSWIRE) -- ASLAN announced in July 2018 that it has received clinical trial authorisation in Singapore to conduct a Phase I study of ASLAN004 for the treatment of...
Edison issues outlook on SDX Energy (SDX)
July 03, 2018 06:16 ET
|
Edison Group
LONDON, July 03, 2018 (GLOBE NEWSWIRE) -- In this note, we revisit SDX’s 2017/2018 gas discoveries in Morocco and Egypt and look ahead at the company’s plans to leverage this success to deepen its...
Edison issues update on Quantum Genomics (ALQGC)
June 28, 2018 06:57 ET
|
Edison Group
LONDON, June 28, 2018 (GLOBE NEWSWIRE) -- In April, Quantum Genomics announced it would be moving forward with the Phase IIb trial in heart failure and has recently announced the design of this...
Edison issues initiation on BONESUPPORT (BONEX)
June 21, 2018 10:35 ET
|
Edison Group
LONDON, U.K., June 21, 2018 (GLOBE NEWSWIRE) -- BONESUPPORT is commercialising synthetic bone graft substitutes. The company invests in R&D to support continued development of innovative...
Edison issues outlook on DeA Capital (DEA)
June 12, 2018 05:50 ET
|
Edison Group
LONDON, June 12, 2018 (GLOBE NEWSWIRE) -- Over the past year, DeA Capital (DeA) has continued to make good progress in implementing the growth strategy for its alternative asset management (AAM)...
Edison issues outlook on Hurricane Energy (HUR)
June 11, 2018 06:24 ET
|
Edison Group
LONDON, June 11, 2018 (GLOBE NEWSWIRE) -- The development of Hurricane’s Lancaster early production system (EPS) remains on track for H119 first oil. We estimate a 1 January 2018 point-forward IRR...
Edison issues outlook on Findel (FDL)
June 08, 2018 05:42 ET
|
Edison Group
LONDON, June 08, 2018 (GLOBE NEWSWIRE) -- Findel (FDL) is seeing outstanding success with its online-led value retail strategy. FY18’s 21% PBT growth includes a strong Black Friday and Christmas...
Edison issues update on ASLAN Pharmaceuticals (ASLN)
June 07, 2018 19:08 ET
|
Edison Group
LONDON, June 08, 2018 (GLOBE NEWSWIRE) -- ASLAN presented data at ASCO from a Phase Ib dosing study examining varlitinib in combination with carboplatin, paclitaxel and Herceptin. Patients were...
Edison issues initiation on InMed Pharmaceuticals (IN)
June 07, 2018 18:39 ET
|
Edison Group
LONDON, June 07, 2018 (GLOBE NEWSWIRE) -- InMed is a Canada-based biopharmaceutical company focused on maximizing the therapeutic potential of cannabinoids. Through its biosynthesis platform, the...
Edison Investment Research Issues Statement on Akari Therapeutics' statements and SEC Filing citing Edison
May 12, 2017 06:00 ET
|
Edison Group
NEW YORK, May 12, 2017 (GLOBE NEWSWIRE) -- Edison Investment Research Inc. (“Edison”), an investment research and advisory company, wishes to comment on statements made by Akari Therapeutics...